What CRISPR-based Diagnostic (SHERLOCK/DETECTR) Is
CRISPR-based diagnostic tools such as SHERLOCK (Specific High-sensitivity Enzymatic Reporter UnLOCKing) and DETECTR (DNA Endonuclease Targeted CRISPR Trans Reporter) leverage the Cas12 and Cas13 enzymes, respectively. These systems are designed to detect specific RNA or DNA sequences associated with pathogens like viruses, providing a rapid and accurate diagnostic method.
The key feature of these tools is their ability to amplify a small amount of target nucleic acid through collateral activation, where the presence of the target sequence causes the Cas enzyme to cleave non-targeted reporter molecules. This process generates a detectable signal, such as fluorescence or color change, indicating the presence of the pathogen.
How SHERLOCK and DETECTR Work
SHERLOCK uses Cas12 to cleave non-targeted reporter molecules in the presence of a specific RNA sequence. The cleavage releases a single-stranded DNA that can hybridize with a fluorescently labeled guide RNA, leading to a detectable signal.
DETECTR employs Cas13 for similar amplification but is particularly effective against RNA targets. When the target RNA binds to the Cas13 enzyme, it causes collateral cleavage of nearby non-targeted RNAs, which can then be detected as a reporter signal.
Why It Matters
CRISPR-based diagnostics are crucial for rapid pathogen detection in clinical settings and public health emergencies. They offer high sensitivity and specificity, making them ideal for early diagnosis of infectious diseases.
These tools also enable point-of-care testing, reducing the time from sample to result and improving patient outcomes by facilitating timely treatment.
Real-World Applications
SHERLOCK and DETECTR have been used in various applications, including diagnosing viral infections like SARS-CoV-2. They can be adapted to detect a wide range of pathogens, making them valuable tools in both research and clinical settings.
These diagnostic methods are also being explored for environmental monitoring, food safety testing, and even personalized medicine.
Frequently asked questions
How does SHERLOCK differ from DETECTR?
SHERLOCK uses Cas12 to target DNA sequences, while DETECTR employs Cas13 for RNA detection. Both systems rely on collateral activation to generate a detectable signal.
What are the advantages of CRISPR-based diagnostics over traditional methods?
CRISPR-based diagnostics offer high sensitivity and specificity, rapid results, and the ability to target specific sequences. They can be adapted for various applications, making them more versatile than many traditional diagnostic tools.
Can these systems detect multiple pathogens at once?
Yes, CRISPR-based diagnostics can be designed to detect multiple targets simultaneously by using different guide RNAs or reporter molecules.
What are the limitations of SHERLOCK and DETECTR?
While highly sensitive, these systems may require optimization for certain target sequences. Additionally, they rely on specific Cas enzymes that must be carefully selected and optimized for each application.
Try it live
Everything above runs in your browser — open CRISPR-based Diagnostic (SHERLOCK/DETECTR) and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open CRISPR-based Diagnostic (SHERLOCK/DETECTR) simulation